SB256
Senate · 2026 sessionRepublicanInterim studySafety rules for clinician-administered drugs
AI-generatedEstablishes safety and procedural requirements governing the administration of clinician-administered drugs.
(New Title) establishing safety and care requirements for clinician-administered drugs.Official record
Public and Mental HealthOccupational RegulationAI-generated
Division of testimonyComputed by this site
3 submissionsNeutral 0
Status
Referred to interim study (House) · May 14, 2026- ✓Introduced
- ✓Senate
- House
- Governor
- Law
The record · every submission as filed
3 submissions| Expand | |||||
|---|---|---|---|---|---|
Sam Hallemeier for PCMA Washington, DC Position recorded without written comment. | Washington, DC, DC | Oppose | — | Apr 7, 2026 | |
Nicholas Telesco for NNECOS and ASCO Alexandria Position recorded without written comment. | Alexandria, VA | Support | — | Apr 7, 2026 | |
Cory Stone for Myself DOVER Position recorded without written comment. | DOVER | Support | — | Apr 7, 2026 |